Hub : Traits :

Chronotype (morning person)

485 significantly associated models · 171 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	7135268	8695522	3	2	1.9e-25	4.6e-24	2.3e-03	91	TNFRSF9 VAMP3
2	1	15569712	16098866	1	1	1.3e-07	1.3e-07	5.8e-02	87	CASP9
3	1	19293249	22200998	5	2	5.5e-12	8.3e-12	8.8e-01	100	HP1BP3 HTR6
4	1	37270283	38679381	1	1	1.9e-07	1.0e-07	2.1e-01	95	MEAF6
5	1	92608852	94120642	1	1	2.2e-08	9.0e-08	2.0e-01	94	FAM69A
6	1	109126153	110834259	4	2	3.0e-10	5.7e-12	NaN	NaN	AMIGO1 GNAI3
7	1	114417843	115823387	2	1	1.5e-09	1.9e-08	1.9e-02	82	TRIM33
8	1	149672809	151659071	14	10	3.7e-16	6.3e-15	1.0e+00	100	ANXA9 C1orf54 CTSS GOLPH3L MRPS21 RPRD2 SETDB1 TARS2
9	1	179566296	180095451	1	1	7.7e-08	1.5e-04	1.3e-03	28	TOR1AIP2
10	1	181669986	183058898	1	1	3.1e-08	1.2e-39	3.5e-33	17	GLUL
11	2	43844833	45285952	1	1	5.7e-09	1.7e-11	3.1e-04	71	PREPL
12	2	48072855	49519654	2	2	1.1e-09	2.9e-09	1.0e+00	100	LHCGR STON1
13	2	60707588	62107632	1	1	1.6e-07	2.5e-10	2.8e-04	67	AHSA2
14	2	197745121	200117777	3	1	2.6e-09	1.1e-11	3.1e-05	62	PLCL1
15	2	238435241	239996179	3	2	7.3e-24	3.9e-25	1.0e+00	100	KLHL30 TRAF3IP1
16	3	22551223	24327558	1	1	1.3e-07	1.5e-08	3.3e-03	73	UBE2E2
17	3	48012797	51320800	18	12	1.1e-14	9.2e-12	NaN	NaN	BSN CYB561D2 HYAL1 RASSF1 SEMA3B-AS1 SEMA3F TCTA U73166.2
18	3	132509832	133350222	1	1	1.0e-09	8.0e-09	1.7e-02	83	TMEM108
19	4	305291	2058475	5	1	1.9e-13	2.9e-08	6.1e-02	89	UVSSA
20	4	82578407	84048087	2	2	1.0e-08	5.0e-11	2.1e-03	78	HNRNPD HNRNPDL
21	5	86867897	88427942	1	1	2.5e-09	1.2e-09	4.5e-06	43	TMEM161B-AS1
22	5	151529317	152030714	1	1	6.1e-09	3.2e-12	1.8e-05	62	NMUR2
23	6	41058968	42450682	2	3	3.8e-09	4.2e-10	6.9e-02	92	FOXP4 PRICKLE4
24	6	152608067	154022718	2	2	7.5e-09	2.5e-19	4.8e-13	35	MTRF1L RP1-101K10.6
25	7	49817957	51215365	2	1	6.1e-08	5.4e-11	1.0e-04	65	FIGNL1
26	7	101330734	103489729	14	11	1.5e-13	2.8e-14	NaN	NaN	ARMC10 NAPEPLD PMPCB POLR2J3 PRKRIP1 RASA4 RP11-514P8.6 RP11-514P8.8 SLC26A5
27	7	115680998	116397572	1	1	2.9e-07	1.0e-08	5.2e-04	63	CAV2
28	8	101232701	102664291	1	1	2.7e-10	1.2e-09	6.8e-01	100	YWHAZ
29	9	36590588	37277603	1	1	8.7e-11	9.4e-10	1.8e-02	85	PAX5
30	9	85899677	87315117	2	1	2.1e-09	3.6e-09	3.2e-01	97	RMI1
31	9	114896872	115476640	1	1	4.2e-08	2.1e-08	1.8e-01	94	HSDL2
32	9	126421143	127872298	1	1	6.0e-08	1.0e-09	5.8e-09	9	PSMB7
33	9	131169528	132569553	4	1	7.9e-10	5.2e-10	3.9e-03	78	PPP2R4
34	9	138605924	141054761	4	2	6.2e-10	5.8e-08	6.1e-02	88	MRPL41 SDCCAG3
35	10	103807817	105275242	1	1	2.3e-07	3.2e-06	5.6e-01	98	C10orf26
36	10	122989048	124407934	1	1	1.9e-07	5.0e-08	5.6e-05	45	RP11-500G22.2
37	11	29713564	31288160	1	1	5.1e-09	2.5e-09	7.2e-03	80	MPPED2
38	11	46578400	48028343	4	1	7.3e-15	1.1e-07	4.6e-01	98	MADD
39	11	56716782	58178587	2	1	5.6e-08	7.7e-10	2.2e-06	41	AP000662.4
40	11	65151449	66919278	4	2	6.2e-08	2.5e-07	9.3e-02	89	CTD-3074O7.5 PACS1
41	12	32831091	34826574	2	3	1.3e-18	1.1e-25	4.3e-05	85	ALG10 SYT10
42	12	38353816	39998144	3	2	5.4e-24	4.4e-26	4.7e-02	96	ALG10B RP11-396F22.1
43	12	106675236	108179234	2	2	1.6e-07	1.8e-08	3.8e-03	74	CRY1 MTERFD3
44	12	111385296	113517494	3	1	4.6e-08	5.3e-09	3.5e-02	87	HECTD4
45	12	120242845	121660787	2	1	2.9e-08	3.4e-07	5.1e-02	85	COQ5
46	13	76867667	78295338	2	1	2.8e-16	3.5e-17	1.0e+00	100	CLN5
47	13	93183161	95758325	1	1	9.5e-09	1.2e-08	1.0e+00	100	GPC6
48	14	60517036	62134085	1	1	1.1e-07	9.4e-06	1.9e-02	72	MNAT1
49	14	73724767	75366447	2	1	9.9e-08	5.7e-07	1.0e+00	100	LIN52
50	14	88690885	89265337	1	1	5.2e-08	3.9e-07	6.9e-02	87	PTPN21
51	14	100766664	101281436	1	1	1.2e-07	3.7e-08	1.5e-02	80	BEGAIN
52	16	52828325	54235440	1	1	2.7e-07	1.5e-20	9.0e-15	30	AKTIP
53	16	55697964	57157206	1	1	1.1e-08	1.1e-15	3.1e-10	38	AMFR
54	16	71380320	72800567	1	1	4.2e-08	8.7e-10	5.3e-03	79	TXNL4B
55	17	7379650	8823768	3	1	3.6e-15	2.8e-15	1.0e+00	100	TMEM107
56	17	33204020	35123256	4	1	1.4e-10	7.2e-09	1.0e+00	100	AP2B1
57	17	45337417	46721406	1	1	1.1e-07	1.4e-06	4.2e-01	97	RP11-6N17.6
58	17	56362067	57989860	3	1	1.2e-08	5.5e-08	1.7e-01	94	TRIM37
59	17	60399470	62212520	2	1	5.0e-08	4.3e-09	1.1e-03	69	CYB561
60	18	52750469	54144903	1	1	8.9e-11	1.4e-08	2.5e-02	84	RP11-397A16.2
61	18	56118999	57521875	1	1	1.4e-12	3.6e-16	5.3e-05	75	SEC11C
62	19	17412366	18811966	1	1	4.7e-08	4.3e-08	7.9e-04	62	ARRDC2
63	19	36694438	37221835	1	1	1.0e-07	2.3e-05	3.7e-01	96	ZNF566
64	19	42331992	42820530	1	1	3.3e-09	2.2e-06	6.3e-01	99	ZNF574
65	19	45313715	46693262	1	1	7.9e-08	2.5e-06	1.1e-05	13	PPM1N
66	19	46754714	47235715	1	1	2.3e-07	5.5e-08	1.3e-02	79	PNMAL2
67	19	58244898	59095126	3	1	1.5e-07	2.1e-07	4.1e-01	98	ZNF584
68	22	40500313	41047764	2	1	5.8e-16	1.3e-16	1.0e+00	100	SGSM3
69	22	41498627	43226599	3	1	1.0e-08	1.0e-09	2.2e-07	28	SLC25A5P1

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Bipolar Disorder (2018)	1.75	4	0	0.0	0.35	6.5e-01	CTD-3074O7.5 HTR6 PACS1 RPRD2
Bipolar Disorder or Schizophrenia	1.47	4	3	6.7	0.86	1.4e-01	CTD-3074O7.5 PACS1 RPRD2 TMEM108
Depressed Affect (Nagel 2018)	1.40	4	1	2.2	-1.00	1.9e-03	AMIGO1 HYAL1 SEMA3F TCTA
Depression (Nagel 2018)	2.35	5	0	0.0	-0.99	1.3e-06	AP000662.4 HYAL1 RASSF1 SEMA3B-AS1 U73166.2
Intelligence (Savage-Jansen 2018)	1.63	10	6	13.3	0.11	7.6e-01	HYAL1 MADD PLCL1 PPP2R4 RASSF1 RMI1 SEMA3F SLC25A5P1 TCTA TRIM37
Neuroticism (Nagel 2018)	1.86	9	3	6.7	-0.81	2.5e-03	AP000662.4 CYB561D2 HP1BP3 HYAL1 PAX5 RASSF1 SEMA3B-AS1 SEMA3F U73166.2
Schizophrenia (2018)	1.49	6	0	0.0	0.08	8.8e-01	C10orf26 CTD-3074O7.5 FIGNL1 RP11-397A16.2 TMEM161B-AS1 TNFRSF9
Schizophrenia vs Biploar Disorder	1.96	2	0	0.0	0.00	1.0e+00	PAX5 SEMA3F
Worry (Nagel 2018)	2.41	7	5	11.1	-0.84	1.1e-03	CYB561D2 HP1BP3 HYAL1 RASSF1 RMI1 SEMA3B-AS1 U73166.2
Alzheimer’s Disease (in mother)	1.36	1	0	0.0	0.00	1.0e+00	PAX5
Alzheimer’s Disease (including proxy)	0.99	1	0	0.0	0.00	1.0e+00	PAX5
Crohns Disease (2017)	1.54	6	2	4.4	0.98	6.7e-04	AHSA2 GOLPH3L HYAL1 SDCCAG3 SEMA3F SETDB1
Irritable Bowel Disease (IBD)	1.93	8	5	11.1	0.99	6.4e-06	AHSA2 CTSS GOLPH3L HYAL1 SDCCAG3 SEMA3F SETDB1 TCTA
Ulcerative Colitis (UC)	1.96	7	2	4.4	0.98	8.2e-05	AHSA2 GOLPH3L HYAL1 SDCCAG3 SEMA3F SETDB1 TCTA
Reaction Time	1.91	4	2	4.4	0.42	4.8e-01	ALG10 HECTD4 PREPL RMI1
Verbal and Numeric Reasoning (VNR)	1.51	6	3	6.7	0.36	4.8e-01	HYAL1 RASSF1 SEMA3F SLC25A5P1 TCTA TRIM37
Breast Cancer	1.27	2	1	2.2	0.00	1.0e+00	AKTIP RASA4
Ovarian Cancer	0.90	1	0	0.0	0.00	1.0e+00	RP11-6N17.6
Prostate Cancer	1.60	2	0	0.0	0.00	1.0e+00	NMUR2 RP11-6N17.6
Age at First Birth	1.52	2	1	2.2	0.00	1.0e+00	HYAL1 SEMA3F
Bipolar Disorder (2011)	2.25	2	0	0.0	0.00	1.0e+00	CTD-3074O7.5 PACS1
Body Mass Index (BMI) (2010)	1.86	1	1	2.2	0.00	1.0e+00	AKTIP
Coronary Artery Disease (CAD)	1.12	1	0	0.0	0.00	1.0e+00	HECTD4
Crohns Disease (2012)	1.36	1	0	0.0	0.00	1.0e+00	SEMA3F
HDL Cholesterol	0.98	1	1	2.2	0.00	1.0e+00	MADD
LDL Cholesterol	1.63	3	1	2.2	0.00	1.0e+00	AMIGO1 GNAI3 HECTD4
Neuroticism (2016)	1.88	2	0	0.0	0.00	1.0e+00	PAX5 U73166.2
Primary Biliary Cirrhosis	1.05	1	0	0.0	0.00	1.0e+00	HECTD4
Schizophrenia (2014)	1.54	4	0	0.0	-0.37	6.3e-01	PAX5 RP11-397A16.2 RPRD2 TMEM161B-AS1
Ulcerative Colitis	2.25	4	1	2.2	1.00	4.0e-03	HYAL1 POLR2J3 SEMA3F TCTA
Blood Eosinophil Count	1.72	19	12	26.7	-0.18	4.2e-01	AHSA2 CTSS CYB561D2 FOXP4 GOLPH3L HECTD4 HNRNPDL HP1BP3 HYAL1 MRPS21 PSMB7 RASSF1 RMI1 SDCCAG3 SEMA3F SETDB1 TARS2 TNFRSF9 ZNF574
Blood Platelet Count	1.33	26	18	40.0	0.34	6.2e-02	AP000662.4 AP2B1 C1orf54 CTSS CYB561D2 GOLPH3L HYAL1 MRPS21 PPM1N PTPN21 RASSF1 RMI1 RP11-397A16.2 RP11-6N17.6 RPRD2 SEMA3B-AS1 SETDB1 SLC25A5P1 TARS2 TMEM161B-AS1 TNFRSF9 TRIM33 U73166.2 VAMP3 YWHAZ ZNF584
Blood Red Count	3.85	21	14	31.1	-0.40	5.9e-02	CTD-3074O7.5 CYB561D2 FAM69A FIGNL1 HECTD4 HP1BP3 LIN52 MEAF6 PPM1N PPP2R4 PRICKLE4 RASSF1 RP11-6N17.6 SEMA3B-AS1 SGSM3 TCTA TOR1AIP2 TRIM33 UBE2E2 VAMP3 ZNF584
Blood White Count	1.42	15	8	17.8	-0.01	9.7e-01	AHSA2 FAM69A HECTD4 HNRNPDL HTR6 HYAL1 MRPS21 RMI1 RP1-101K10.6 RP11-6N17.6 SDCCAG3 SEMA3F TARS2 ZNF574 ZNF584
Heel T-Score	0.97	14	9	20.0	-0.26	3.7e-01	ANXA9 AP000662.4 BSN CTSS FOXP4 GOLPH3L GPC6 PSMB7 RMI1 RP11-500G22.2 SEMA3F TCTA TNFRSF9 UVSSA
BMI	2.09	22	10	22.2	0.17	4.5e-01	AKTIP ARRDC2 CASP9 CTD-3074O7.5 FAM69A FIGNL1 GNAI3 HYAL1 MADD MPPED2 MTRF1L PAX5 PLCL1 PPM1N PSMB7 SEMA3F SETDB1 SGSM3 SLC25A5P1 TCTA TMEM161B-AS1 YWHAZ
Height	1.15	37	23	51.1	-0.09	5.7e-01	ANXA9 C1orf54 CRY1 CTD-3074O7.5 CTSS CYB561D2 FAM69A GOLPH3L HECTD4 HNRNPD HP1BP3 HSDL2 HYAL1 LIN52 MNAT1 MPPED2 MRPS21 PLCL1 PREPL PRICKLE4 PRKRIP1 PTPN21 RASSF1 RMI1 RP11-397A16.2 RP11-500G22.2 RP11-6N17.6 SDCCAG3 SETDB1 TMEM107 TRAF3IP1 TRIM33 TXNL4B U73166.2 UBE2E2 UVSSA ZNF574
Waist Hip Ratio (WHR)	1.52	13	6	13.3	-0.66	3.9e-03	ALG10 ALG10B ANXA9 CYB561D2 HYAL1 MNAT1 RASSF1 RP11-397A16.2 SEMA3B-AS1 TRIM33 U73166.2 UVSSA YWHAZ
Systolic Blood Pressure	1.01	8	4	8.9	-0.11	7.9e-01	AP000662.4 C10orf26 CASP9 HECTD4 MADD PSMB7 RP11-6N17.6 SGSM3
Smoking Status	1.70	5	1	2.2	-0.78	1.2e-01	BSN SGSM3 SLC25A5P1 TCTA TMEM161B-AS1
Allergy or Eczema	1.44	6	1	2.2	0.10	8.5e-01	AHSA2 CTD-3074O7.5 NMUR2 PLCL1 TNFRSF9 ZNF574
Cardiovascular Disease	0.99	5	2	4.4	0.56	3.2e-01	AHSA2 HECTD4 MADD PLCL1 TMEM161B-AS1
Hypothyroidism (self reported)	1.17	2	1	2.2	0.00	1.0e+00	HECTD4 PSMB7
Respiratory disease	1.44	3	0	0.0	0.00	1.0e+00	HYAL1 SEMA3F TARS2
Type 2 Diabetes (T2D) (2018)	1.92	7	1	2.2	-0.31	4.5e-01	AKTIP PAX5 PMPCB POLR2J3 PPM1N PRKRIP1 RP11-514P8.6
Lung FEV1/FVC ratio	1.21	17	4	8.9	-0.09	7.3e-01	AHSA2 AP000662.4 C1orf54 FAM69A GOLPH3L HNRNPD LIN52 MRPS21 PLCL1 PNMAL2 PPM1N PPP2R4 SETDB1 SLC26A5 TARS2 TRAF3IP1 TRIM33
Lung FVC	1.87	20	6	13.3	-0.25	2.5e-01	ANXA9 BEGAIN C1orf54 CTSS CYB561D2 GOLPH3L HYAL1 MNAT1 MRPS21 PNMAL2 PRICKLE4 RASSF1 RMI1 SDCCAG3 SEMA3B-AS1 SETDB1 SLC25A5P1 TCTA U73166.2 ZNF574
Neuroticism	1.77	9	2	4.4	-0.78	7.6e-03	AP000662.4 CYB561D2 HP1BP3 HYAL1 PAX5 RASSF1 SEMA3B-AS1 SEMA3F U73166.2
Hair Pigment	0.16	9	3	6.7	-0.35	3.6e-01	HECTD4 MADD MNAT1 MRPS21 RP11-6N17.6 RPRD2 SDCCAG3 SGSM3 TRIM37
Tanning	0.29	5	3	6.7	-0.74	1.6e-01	CTSS GOLPH3L SETDB1 TMEM161B-AS1 ZNF574
Hand grip strength (left)	1.44	5	0	0.0	-0.43	4.7e-01	ANXA9 PPP2R4 RP11-6N17.6 SETDB1 UVSSA
Number of treatments/medications taken	1.60	2	1	2.2	0.00	1.0e+00	HYAL1 SEMA3F
Sensitivity / hurt feelings	1.57	1	0	0.0	0.00	1.0e+00	RMI1
Frequency of depressed mood in last 2 weeks	2.53	5	0	0.0	-0.99	1.6e-05	AP000662.4 HYAL1 RASSF1 SEMA3B-AS1 U73166.2
Relative age of first facial hair	2.10	7	1	2.2	-0.47	2.4e-01	AHSA2 BSN CYB561D2 HYAL1 PRICKLE4 RASSF1 ZNF584
Other serious medical condition/disability diagnosed by doctor	1.42	1	0	0.0	0.00	1.0e+00	PRICKLE4
Ever used hormone-replacement therapy (HRT)	1.01	1	0	0.0	0.00	1.0e+00	PSMB7
Systolic blood pressure, automated reading	0.92	2	1	2.2	0.00	1.0e+00	C10orf26 HECTD4
Medication: Metformin	1.45	1	1	2.2	0.00	1.0e+00	PPM1N
Pack years adult smoking proportion	1.55	1	0	0.0	0.00	1.0e+00	CYB561
Impedance of leg (right)	2.48	19	13	28.9	-0.60	3.1e-03	AKTIP C1orf54 CTD-3074O7.5 CTSS CYB561D2 GOLPH3L HNRNPD HYAL1 MADD MPPED2 MRPS21 PLCL1 RASSF1 RP11-6N17.6 RPRD2 SEMA3B-AS1 TARS2 U73166.2 YWHAZ
Leg fat-free mass (left)	1.48	16	6	13.3	0.21	4.4e-01	AKTIP ANXA9 C1orf54 FIGNL1 HECTD4 HYAL1 MADD MNAT1 MPPED2 MRPS21 PAX5 PLCL1 SEMA3F SLC25A5P1 UVSSA YWHAZ
Trunk fat percentage	1.62	13	3	6.7	0.23	4.6e-01	AKTIP BEGAIN GNAI3 GOLPH3L HNRNPD HYAL1 MADD MPPED2 PAX5 POLR2J3 RMI1 SEMA3F TMEM161B-AS1
Hand grip strength (right)	1.35	2	0	0.0	0.00	1.0e+00	ANXA9 UVSSA
Current tobacco smoking	1.30	1	0	0.0	0.00	1.0e+00	SGSM3
Fed-up feelings	1.42	4	1	2.2	-1.00	4.0e-03	HECTD4 HYAL1 SEMA3F TCTA
Frequency of unenthusiasm / disinterest in last 2 weeks	2.22	4	0	0.0	-1.00	1.4e-05	AP000662.4 HYAL1 RASSF1 U73166.2
Relative age voice broke	1.44	1	0	0.0	0.00	1.0e+00	ZNF584
Taking other prescription medications	2.15	3	2	4.4	-0.99	1.1e-02	HYAL1 RASSF1 SEMA3F
Age when periods started (menarche)	2.21	10	5	11.1	-0.38	2.5e-01	AKTIP BSN C1orf54 HYAL1 MADD PRICKLE4 RP11-500G22.2 SEMA3F TCTA ZNF584
Heel bone mineral density (BMD) T-score, automated (left)	0.99	3	1	2.2	0.00	1.0e+00	BSN RP11-500G22.2 UVSSA
High blood pressure	0.93	4	1	2.2	-0.25	7.5e-01	AHSA2 GNAI3 HECTD4 MADD
Hayfever, allergic rhinitis or eczema	1.45	4	0	0.0	-0.61	3.9e-01	AHSA2 CYB561D2 PLCL1 RASSF1
Supplements: Glucosamine	1.24	1	0	0.0	0.00	1.0e+00	TARS2
Medication: Atenolol	0.93	1	0	0.0	0.00	1.0e+00	HECTD4
Medication: Levothyroxine sodium	1.25	1	1	2.2	0.00	1.0e+00	HECTD4
Sitting height	0.93	14	6	13.3	-0.13	6.5e-01	ARMC10 C1orf54 CRY1 FAM69A MNAT1 MPPED2 MRPS21 NAPEPLD POLR2J3 RP11-514P8.8 SDCCAG3 TMEM107 UBE2E2 ZNF574
Body mass index (BMI)	1.89	12	8	17.8	0.15	6.3e-01	AKTIP CTD-3074O7.5 GNAI3 HECTD4 HYAL1 MADD MPPED2 PAX5 PLCL1 SEMA3F SGSM3 YWHAZ
Impedance of leg (left)	2.33	17	11	24.4	-0.69	7.2e-04	AKTIP C1orf54 CTD-3074O7.5 CYB561D2 HNRNPD HYAL1 MADD MPPED2 MRPS21 PLCL1 RASSF1 RP11-6N17.6 RPRD2 SEMA3B-AS1 TARS2 U73166.2 YWHAZ
Leg predicted mass (left)	1.49	17	5	11.1	0.17	5.2e-01	AKTIP ANXA9 C1orf54 FIGNL1 HECTD4 HYAL1 MADD MNAT1 MPPED2 MRPS21 PAX5 PLCL1 SEMA3F SLC25A5P1 TMEM107 UVSSA YWHAZ
Trunk fat mass	1.63	13	5	11.1	0.00	1.0e+00	AKTIP FIGNL1 GNAI3 HECTD4 HNRNPD HYAL1 MADD MPPED2 PAX5 POLR2J3 RMI1 SEMA3F TMEM161B-AS1
Waist circumference	1.66	12	4	8.9	-0.03	9.2e-01	AKTIP FIGNL1 GNAI3 HECTD4 HYAL1 MADD MPPED2 MTRF1L PAX5 SEMA3F SGSM3 TRIM33
Past tobacco smoking	1.48	1	0	0.0	0.00	1.0e+00	TMEM161B-AS1
Alcohol usually taken with meals	1.39	3	0	0.0	0.00	1.0e+00	AP000662.4 PRICKLE4 RMI1
Nervous feelings	2.12	7	2	4.4	-0.74	2.2e-02	CYB561D2 HYAL1 MNAT1 RASSF1 SEMA3B-AS1 U73166.2 UVSSA
Frequency of tenseness / restlessness in last 2 weeks	1.82	2	0	0.0	0.00	1.0e+00	HYAL1 SEMA3F
Forced vital capacity (FVC)	1.35	8	5	11.1	-0.42	2.6e-01	ANXA9 CRY1 CTSS GOLPH3L RP11-397A16.2 SETDB1 TXNL4B ZNF574
Heel bone mineral density (BMD) T-score, automated (right)	1.20	4	1	2.2	-0.69	2.0e-01	ALG10 BSN RP11-500G22.2 UVSSA
Ever unenthusiastic/disinterested for a whole week	2.78	6	0	0.0	-0.99	6.2e-06	BSN HYAL1 RASSF1 SEMA3F TCTA U73166.2
Qualifications: None of the above	1.58	6	2	4.4	-0.72	1.1e-01	AP000662.4 BSN HYAL1 LIN52 SEMA3F TCTA
Mouth/teeth dental problems	0.99	1	0	0.0	0.00	1.0e+00	NMUR2
Allergy	1.58	6	0	0.0	0.78	3.7e-02	AHSA2 CTD-3074O7.5 CYB561D2 HYAL1 RASSF1 ZNF574
Diabetes (self-reported)	1.66	2	0	0.0	0.00	1.0e+00	PMPCB PPM1N
Medication: Simvastatin	1.42	1	1	2.2	0.00	1.0e+00	AMIGO1
Fluid intelligence score	1.47	4	2	4.4	0.59	4.1e-01	AHSA2 HYAL1 SEMA3F TRIM37
Neuroticism score	2.19	9	5	11.1	-0.85	4.4e-04	AP000662.4 CYB561D2 HP1BP3 HYAL1 PAX5 RASSF1 SEMA3B-AS1 SEMA3F U73166.2
Weight	1.63	15	7	15.6	0.02	9.5e-01	AKTIP FIGNL1 GNAI3 GPC6 HECTD4 HYAL1 MADD MNAT1 MPPED2 PAX5 PLCL1 POLR2J3 SEMA3F SLC25A5P1 YWHAZ
Impedance of arm (right)	2.18	17	11	24.4	-0.17	4.6e-01	AKTIP CYB561D2 GOLPH3L HNRNPD HYAL1 NAPEPLD PLCL1 PPP2R4 PSMB7 RASA4 RASSF1 RMI1 RP11-6N17.6 SEMA3B-AS1 SEMA3F U73166.2 YWHAZ
Arm fat percentage (right)	1.67	11	5	11.1	0.11	7.5e-01	AKTIP CTD-3074O7.5 GNAI3 HYAL1 MADD MPPED2 PAX5 POLR2J3 SEMA3F SGSM3 TMEM161B-AS1
Trunk fat-free mass	1.42	19	7	15.6	0.03	8.9e-01	AKTIP C1orf54 CRY1 FIGNL1 GPC6 HECTD4 HSDL2 HYAL1 MNAT1 MPPED2 MRPS21 NAPEPLD PLCL1 POLR2J3 SDCCAG3 SEMA3F SLC25A5P1 TMEM107 UVSSA
Hip circumference	1.65	12	6	13.3	0.11	7.3e-01	AKTIP AMFR FIGNL1 GNAI3 HECTD4 MADD MPPED2 PAX5 PMPCB SEMA3F SETDB1 YWHAZ
Alcohol intake versus 10 years previously	1.73	2	1	2.2	0.00	1.0e+00	HYAL1 SEMA3F
Worrier / anxious feelings	2.10	5	3	6.7	-0.98	7.1e-04	HP1BP3 HYAL1 RASSF1 SEMA3B-AS1 U73166.2
Frequency of tiredness / lethargy in last 2 weeks	2.12	4	0	0.0	-1.00	7.3e-04	AP000662.4 BSN HECTD4 TCTA
Falls in the last year	1.39	1	0	0.0	0.00	1.0e+00	MPPED2
Hair/balding pattern: Pattern 3	1.00	1	0	0.0	0.00	1.0e+00	ALG10
Number of live births	1.53	1	0	0.0	0.00	1.0e+00	PTPN21
Forced expiratory volume in 1-second (FEV1)	1.16	6	2	4.4	-0.49	2.7e-01	ANXA9 CTSS GOLPH3L SETDB1 TCTA ZNF574
Pulse rate	2.01	3	1	2.2	0.99	8.0e-03	ALG10 ALG10B BSN
Qualifications: A levels/AS levels or equivalent	1.51	3	2	4.4	0.00	1.0e+00	HYAL1 SEMA3F TCTA
Mouth/teeth dental problems: Dentures	1.12	1	0	0.0	0.00	1.0e+00	SEMA3F
Asthma	1.39	1	0	0.0	0.00	1.0e+00	SEMA3F
Medication: Ibuprofen (e.g. Nurofen)	1.21	2	0	0.0	0.00	1.0e+00	HECTD4 TARS2
Medication: Cholesterol lowering	1.48	1	1	2.2	0.00	1.0e+00	AMIGO1
Prospective memory result	1.95	2	0	0.0	0.00	1.0e+00	MADD SETDB1
Forced expiratory volume in 1-second (FEV1), Best measure	1.00	4	1	2.2	-0.99	5.4e-03	ANXA9 CTSS GOLPH3L SETDB1
Impedance of arm (left)	2.09	17	10	22.2	-0.18	4.4e-01	AKTIP CYB561D2 HNRNPD HYAL1 NAPEPLD PLCL1 PPP2R4 PSMB7 RASA4 RASSF1 RMI1 RP11-396F22.1 SEMA3B-AS1 SEMA3F TCTA U73166.2 YWHAZ
Arm fat mass (right)	1.75	14	7	15.6	0.12	6.9e-01	AKTIP FIGNL1 GNAI3 HECTD4 HYAL1 MADD MPPED2 PAX5 PLCL1 SEMA3F SGSM3 SLC25A5P1 TMEM161B-AS1 YWHAZ
Trunk predicted mass	1.42	19	8	17.8	0.04	8.8e-01	AKTIP C1orf54 CRY1 FIGNL1 GPC6 HECTD4 HSDL2 HYAL1 MNAT1 MPPED2 MRPS21 NAPEPLD PLCL1 POLR2J3 SDCCAG3 SEMA3F SLC25A5P1 TMEM107 UVSSA
Standing height	1.16	22	13	28.9	-0.15	4.7e-01	ANXA9 C1orf54 CRY1 CTD-3074O7.5 CYB561D2 FAM69A HECTD4 HNRNPD HP1BP3 HYAL1 MNAT1 MPPED2 MRPS21 PRKRIP1 RASSF1 RMI1 RP11-397A16.2 RP11-6N17.6 SDCCAG3 TMEM107 UVSSA ZNF574
Tense / 'highly strung'	2.26	5	1	2.2	-0.99	4.7e-05	CYB561D2 HYAL1 RASSF1 SEMA3B-AS1 U73166.2
Seen doctor (GP) for nerves, anxiety, tension or depression	2.25	2	1	2.2	0.00	1.0e+00	CTD-3074O7.5 PAX5
Birth weight of first child	1.38	3	0	0.0	0.00	1.0e+00	C10orf26 C1orf54 HECTD4
Peak expiratory flow (PEF)	1.44	3	0	0.0	0.00	1.0e+00	C1orf54 MRPS21 TARS2
Pulse wave reflection index	1.44	1	0	0.0	0.00	1.0e+00	RMI1
Ever highly irritable/argumentative for 2 days	1.96	3	2	4.4	0.00	1.0e+00	HYAL1 RASSF1 SEMA3F
Qualifications: O levels/GCSEs or equivalent	1.14	1	0	0.0	0.00	1.0e+00	PRICKLE4
Medication: Paracetamol	1.23	2	0	0.0	0.00	1.0e+00	BSN TCTA
Headache pain in last month	1.47	3	1	2.2	0.00	1.0e+00	HECTD4 MRPS21 TARS2
Medication for cholesterol, blood pressure or diabetes	1.46	2	0	0.0	0.00	1.0e+00	AKTIP PPM1N
Hypothyroidism/myxoedema (self-reported)	1.12	1	1	2.2	0.00	1.0e+00	HECTD4
Medication: Amlodipine	1.10	2	0	0.0	0.00	1.0e+00	AHSA2 TRIM37
Birth weight	1.68	3	1	2.2	0.00	1.0e+00	C10orf26 MRPS21 TARS2
Forced vital capacity (FVC), Best measure	1.26	6	4	8.9	-0.76	4.9e-02	ANXA9 CRY1 CTSS GOLPH3L SETDB1 ZNF574
Body fat percentage	1.65	11	5	11.1	0.11	7.6e-01	AKTIP BEGAIN GNAI3 GOLPH3L HNRNPD HYAL1 MADD PAX5 POLR2J3 RPRD2 SEMA3F
Leg fat percentage (right)	1.71	9	4	8.9	-0.31	4.2e-01	AKTIP GNAI3 HECTD4 HNRNPD HYAL1 PAX5 POLR2J3 RPRD2 SEMA3F
Arm fat-free mass (right)	1.47	15	6	13.3	-0.04	9.0e-01	AKTIP FIGNL1 HECTD4 HSDL2 HYAL1 MNAT1 MPPED2 NAPEPLD PLCL1 PSMB7 SEMA3F SLC25A5P1 TMEM107 UVSSA YWHAZ
Exposure to tobacco smoke outside home	1.48	1	0	0.0	0.00	1.0e+00	GNAI3
Comparative body size at age 10	2.63	10	3	6.7	0.67	1.6e-02	AKTIP CYB561D2 GNAI3 HNRNPD HYAL1 MADD RASSF1 SEMA3B-AS1 SETDB1 U73166.2
Number of full brothers	1.38	1	0	0.0	0.00	1.0e+00	RP11-397A16.2
Worry too long after embarrassment	1.61	2	1	2.2	0.00	1.0e+00	AP000662.4 HP1BP3
Wheeze or whistling in the chest in last year	1.54	2	1	2.2	0.00	1.0e+00	HYAL1 SEMA3F
Age at first live birth	1.21	2	2	4.4	0.00	1.0e+00	HYAL1 SEMA3F
Health satisfaction	1.62	1	0	0.0	0.00	1.0e+00	RASSF1
Qualifications: College or University degree	1.93	11	3	6.7	0.27	4.2e-01	AP000662.4 BSN HYAL1 PACS1 PTPN21 SEMA3F SETDB1 SLC25A5P1 TCTA TMEM161B-AS1 TXNL4B
Medication for pain relief, constipation, heartburn	1.31	1	0	0.0	0.00	1.0e+00	TARS2
Medication: Allopurinol	0.96	1	0	0.0	0.00	1.0e+00	VAMP3
Medication: Omeprazole	1.78	3	0	0.0	0.00	1.0e+00	MRPS21 RPRD2 TARS2
Mean time to correctly identify matches	1.92	3	2	4.4	0.00	1.0e+00	HECTD4 PREPL RMI1
Heart disease (mother)	0.86	1	0	0.0	0.00	1.0e+00	HECTD4
Whole body fat mass	1.68	11	6	13.3	-0.10	7.8e-01	AKTIP FIGNL1 GNAI3 HECTD4 HYAL1 MADD MPPED2 PAX5 POLR2J3 SEMA3F YWHAZ
Leg fat mass (right)	1.79	11	5	11.1	0.03	9.3e-01	AKTIP FIGNL1 GNAI3 HECTD4 HYAL1 MADD MPPED2 PAX5 PLCL1 SEMA3F YWHAZ
Arm predicted mass (right)	1.50	15	8	17.8	-0.05	8.6e-01	AKTIP FIGNL1 HECTD4 HSDL2 HYAL1 MNAT1 MPPED2 NAPEPLD PLCL1 PSMB7 SEMA3F SLC25A5P1 TMEM107 UVSSA YWHAZ
Pulse rate, automated reading	2.29	13	6	13.3	0.37	1.6e-01	ALG10 ALG10B AP000662.4 BSN HNRNPD PRICKLE4 RASSF1 RP11-396F22.1 SEMA3B-AS1 SYT10 TCTA TMEM161B-AS1 UVSSA
Alcohol intake frequency.	1.13	4	1	2.2	-0.55	4.5e-01	AP000662.4 HYAL1 SEMA3F TXNL4B
Comparative height size at age 10	0.94	11	5	11.1	0.40	2.2e-01	CTD-3074O7.5 HECTD4 HNRNPD HP1BP3 MNAT1 MPPED2 RMI1 SDCCAG3 TMEM107 UVSSA ZNF574
Suffer from 'nerves'	1.19	1	1	2.2	0.00	1.0e+00	MADD
Overall health rating	1.96	6	4	8.9	-0.80	3.0e-02	AP000662.4 HYAL1 PLCL1 RASSF1 SEMA3F TCTA
Age at last live birth	1.52	2	2	4.4	0.00	1.0e+00	HYAL1 SEMA3F
Family relationship satisfaction	1.65	1	0	0.0	0.00	1.0e+00	AMIGO1
Leg pain on walking	1.20	2	0	0.0	0.00	1.0e+00	PLCL1 SEMA3F
Commuting to job workplace: Car/motor vehicle	1.49	1	1	2.2	0.00	1.0e+00	TOR1AIP2
Supplements: Vitamin C	1.19	1	0	0.0	0.00	1.0e+00	PRICKLE4
Knee pain experienced in last month	1.06	1	0	0.0	0.00	1.0e+00	SEMA3F
Hypertension (Self-reported)	0.87	4	0	0.0	-0.23	7.7e-01	AHSA2 GNAI3 HECTD4 MADD
Illnesses of father: Heart disease	1.14	1	0	0.0	0.00	1.0e+00	GNAI3
Smoking status: Previous	1.59	2	0	0.0	0.00	1.0e+00	HECTD4 TMEM161B-AS1
Forced expiratory volume in 1-second (FEV1), predicted	1.36	2	0	0.0	0.00	1.0e+00	CYB561D2 RASSF1
Whole body fat-free mass	1.47	17	8	17.8	-0.06	8.2e-01	AKTIP C1orf54 FIGNL1 GPC6 HECTD4 HYAL1 MNAT1 MPPED2 MRPS21 NAPEPLD PLCL1 POLR2J3 SEMA3F SLC25A5P1 TMEM107 UVSSA YWHAZ
Leg fat-free mass (right)	1.49	15	6	13.3	0.26	3.5e-01	AKTIP ANXA9 C1orf54 FIGNL1 HECTD4 MADD MNAT1 MPPED2 MRPS21 PLCL1 SEMA3F SLC25A5P1 TMEM107 UVSSA YWHAZ
Arm fat percentage (left)	1.68	11	5	11.1	0.13	7.0e-01	AKTIP CTD-3074O7.5 GNAI3 HYAL1 MADD MPPED2 PAX5 POLR2J3 SEMA3F SGSM3 TMEM161B-AS1
Average weekly red wine intake	1.66	1	1	2.2	0.00	1.0e+00	AP000662.4
Mood swings	1.51	3	1	2.2	0.00	1.0e+00	AMIGO1 HYAL1 SEMA3F
Ever had bowel cancer screening	1.52	1	1	2.2	0.00	1.0e+00	PRICKLE4
Diabetes diagnosed by doctor	1.67	5	0	0.0	-0.09	8.9e-01	AKTIP PMPCB POLR2J3 PPM1N PRKRIP1
Friendships satisfaction	2.33	4	0	0.0	0.55	4.5e-01	MRPS21 RP11-397A16.2 RPRD2 TARS2
Qualifications: nursing, teaching	1.50	1	0	0.0	0.00	1.0e+00	RMI1
Mouth/teeth dental problems: Mouth ulcers	1.31	2	0	0.0	0.00	1.0e+00	CTSS GOLPH3L
Back pain experienced in last month	1.16	1	0	0.0	0.00	1.0e+00	HECTD4
Mineral and other dietary supplements	1.19	1	0	0.0	0.00	1.0e+00	PRICKLE4
Asthma (self-reported)	1.34	2	0	0.0	0.00	1.0e+00	CYB561D2 SEMA3F
Osteoporosis (self-reported)	1.10	1	0	0.0	0.00	1.0e+00	RP11-397A16.2
Osteoarthritis (self-reported)	1.81	2	0	0.0	0.00	1.0e+00	MRPS21 RPRD2
Forced expiratory volume in 1-second (FEV1), predicted percentage	1.16	1	0	0.0	0.00	1.0e+00	TCTA
Whole body water mass	1.46	15	8	17.8	0.07	8.0e-01	AKTIP C1orf54 FIGNL1 GPC6 HECTD4 HYAL1 MNAT1 MPPED2 MRPS21 PLCL1 SEMA3F SLC25A5P1 TMEM107 UVSSA YWHAZ
Leg predicted mass (right)	1.49	14	6	13.3	0.31	2.9e-01	AKTIP ANXA9 C1orf54 FIGNL1 HECTD4 MADD MNAT1 MPPED2 MRPS21 PLCL1 SEMA3F SLC25A5P1 UVSSA YWHAZ
Arm fat mass (left)	1.75	14	6	13.3	0.13	6.6e-01	AKTIP FIGNL1 GNAI3 HECTD4 HYAL1 MADD MPPED2 PAX5 PLCL1 SEMA3F SGSM3 SLC25A5P1 TMEM161B-AS1 YWHAZ
Number of self-reported non-cancer illnesses	1.81	3	0	0.0	0.00	1.0e+00	HP1BP3 HYAL1 SEMA3F
Miserableness	1.73	3	3	6.7	0.00	1.0e+00	HYAL1 SEMA3F TCTA
Guilty feelings	1.59	3	0	0.0	0.00	1.0e+00	AP000662.4 MRPS21 TCTA
Tinnitus: Yes, now most or all of the time	1.13	1	0	0.0	0.00	1.0e+00	RP11-6N17.6
Medication: Blood pressure	0.79	2	0	0.0	0.00	1.0e+00	GNAI3 HECTD4
Pain type(s) experienced in last month: Hip pain	1.32	2	0	0.0	0.00	1.0e+00	MRPS21 TARS2
High cholesterol (Self-reported)	1.73	4	1	2.2	0.93	6.6e-02	AMIGO1 CYB561D2 HYAL1 RP11-6N17.6
Medication: Paracetamol	1.31	2	1	2.2	0.00	1.0e+00	BSN TCTA
Ever smoked	1.25	2	0	0.0	0.00	1.0e+00	TCTA TMEM161B-AS1
Basal metabolic rate	1.52	15	8	17.8	-0.10	7.3e-01	AKTIP FIGNL1 GPC6 HECTD4 HYAL1 MNAT1 MPPED2 PAX5 PLCL1 POLR2J3 SEMA3F SLC25A5P1 TMEM107 UVSSA YWHAZ
Leg fat percentage (left)	1.61	9	4	8.9	0.02	9.5e-01	AKTIP BEGAIN GNAI3 HNRNPD HYAL1 MADD PAX5 RPRD2 SEMA3F
Arm fat-free mass (left)	1.56	13	8	17.8	0.03	9.3e-01	AKTIP FIGNL1 HECTD4 HYAL1 MNAT1 MPPED2 PLCL1 PSMB7 SEMA3F SLC25A5P1 TMEM107 UVSSA YWHAZ
Number of operations (self-reported)	1.56	5	0	0.0	-1.00	4.1e-04	BSN HYAL1 PSMB7 SEMA3F TCTA
Average weekly beer plus cider intake	1.76	4	1	2.2	-0.52	3.6e-01	HYAL1 PRICKLE4 SEMA3F TCTA
Irritability	0.94	1	0	0.0	0.00	1.0e+00	PAX5
Risk taking	1.31	1	0	0.0	0.00	1.0e+00	RP11-397A16.2
Diastolic blood pressure, automated reading	1.02	3	1	2.2	0.00	1.0e+00	HECTD4 PAX5 SEMA3F
Ever depressed for a whole week	1.79	1	0	0.0	0.00	1.0e+00	BSN
Vascular/heart problems diagnosed by doctor	0.99	4	0	0.0	0.25	7.5e-01	AHSA2 GNAI3 HECTD4 MADD
Cholesterol lowering medication	1.23	1	0	0.0	0.00	1.0e+00	GNAI3
Medication: Omeprazole (e.g. Zanprol)	1.63	1	0	0.0	0.00	1.0e+00	PRICKLE4
Pain experienced in last month	1.29	2	0	0.0	0.00	1.0e+00	HECTD4 TCTA
Pack years of smoking	1.69	1	0	0.0	0.00	1.0e+00	CYB561
Impedance of whole body	2.32	19	12	26.7	-0.34	1.2e-01	AKTIP CTD-3074O7.5 CYB561D2 GOLPH3L HNRNPD HYAL1 MPPED2 PLCL1 PSMB7 RASSF1 RMI1 RP11-6N17.6 RPRD2 SEMA3B-AS1 SEMA3F TARS2 TCTA U73166.2 YWHAZ
Leg fat mass (left)	1.73	11	5	11.1	0.04	9.0e-01	AKTIP FIGNL1 GNAI3 HECTD4 HYAL1 MADD MPPED2 PAX5 PLCL1 SEMA3F YWHAZ
Arm predicted mass (left)	1.59	16	8	17.8	-0.13	6.3e-01	AKTIP CRY1 FIGNL1 GPC6 HECTD4 HSDL2 HYAL1 MNAT1 MPPED2 PLCL1 POLR2J3 PSMB7 SEMA3F SLC25A5P1 TMEM107 UVSSA

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Adipose Subcutaneous	12	0.344	2.4
GTEx	Adipose Visceral Omentum	5	0.245	2.3
GTEx	Adrenal Gland	3	0.206	2.5
GTEx	Artery Aorta	9	0.302	2.4
GTEx	Artery Coronary	6	0.507	2.5
GTEx	Artery Tibial	11	0.293	2.3
GTEx	Brain Caudate basal ganglia	3	0.326	2.3
GTEx	Brain Cerebellar Hemisphere	5	0.336	2.3
GTEx	Brain Cerebellum	8	0.403	2.4
GTEx	Brain Cortex	4	0.387	2.4
GTEx	Brain Frontal Cortex BA9	1	0.108	2.4
GTEx	Brain Hippocampus	0	0.000	2.3
GTEx	Brain Hypothalamus	0	0.000	2.4
GTEx	Brain Nucleus accumbens basal ganglia	2	0.231	2.3
GTEx	Brain Putamen basal ganglia	6	0.962	2.4
GTEx	Breast Mammary Tissue	11	0.557	2.4
GTEx	Breast Mammary Tissue (Male)	1	0.084	2.1
GTEx	Breast Mammary Tissue (Female)	7	0.426	2.4
GTEx	Cells EBV-transformed lymphocytes	0	0.000	2.5
GTEx	Cells Transformed fibroblasts	13	0.310	2.4
GTEx	Colon Sigmoid	1	0.068	2.3
GTEx	Colon Transverse	11	0.533	2.5
GTEx	Esophagus Gastroesophageal Junction	4	0.277	2.4
GTEx	Esophagus Mucosa	11	0.331	2.4
GTEx	Esophagus Muscularis	15	0.464	2.4
GTEx	Heart Atrial Appendage	6	0.380	2.4
GTEx	Heart Left Ventricle	9	0.588	2.4
GTEx	Liver	2	0.279	2.4
GTEx	Lung	12	0.418	2.5
GTEx	Muscle Skeletal	9	0.311	2.4
GTEx	Nerve Tibial	15	0.347	2.4
GTEx	Ovary	0	0.000	2.2
GTEx	Pancreas	7	0.429	2.4
GTEx	Pituitary	5	0.448	2.5
GTEx	Prostate	4	0.480	2.4
GTEx	Skin Not Sun Exposed Suprapubic	8	0.325	2.4
GTEx	Skin Sun Exposed Lower leg	11	0.302	2.4
GTEx	Small Intestine Terminal Ileum	2	0.433	2.5
GTEx	Spleen	6	0.425	2.4
GTEx	Stomach	3	0.206	2.4
GTEx	Testis	12	0.380	2.4
GTEx	Thyroid	14	0.350	2.4
GTEx	Uterus	3	0.529	2.5
GTEx	Vagina	0	0.000	2.1
GTEx	Whole Blood	8	0.402	2.3
METSIM	Adipose	6	0.130	2.1
NTR	Blood	6	0.250	2.3
ROSMAP	Brain Pre-frontal Cortex	16	0.364	2.4
YFS	Blood	7	0.152	2.2
CommonMind	Brain Pre-frontal Cortex	13	0.242	2.3
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	7	0.422	2.2
The Cancer Genome Atlas	Breast Invasive Carcinoma	17	0.385	2.3
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	0	0.000	2.2
The Cancer Genome Atlas	Colon Adenocarcinoma	5	0.242	2.3
The Cancer Genome Atlas	Esophageal Carcinoma	3	0.437	2.6
The Cancer Genome Atlas	Glioblastoma Multiforme	2	0.195	2.0
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	10	0.366	2.3
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	14	0.341	2.2
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	5	0.243	2.3
The Cancer Genome Atlas	Brain Lower Grade Glioma	13	0.302	2.3
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	3	0.271	2.4
The Cancer Genome Atlas	Lung Adenocarcinoma	7	0.238	2.1
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	6	0.239	2.2
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	3	0.188	2.2
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	2	0.120	2.2
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	0	0.000	2.2
The Cancer Genome Atlas	Prostate Adenocarcinoma	17	0.367	2.3
The Cancer Genome Atlas	Rectum Adenocarcinoma	1	0.144	2.2
The Cancer Genome Atlas	Soft Tissue Sarcoma	2	0.187	2.4
The Cancer Genome Atlas	Skin Cutaneous Melanoma	1	0.187	2.3
The Cancer Genome Atlas	Stomach Adenocarcinoma	6	0.356	2.3
The Cancer Genome Atlas	Testicular Germ Cell Tumors	6	0.469	2.3
The Cancer Genome Atlas	Thyroid Carcinoma	20	0.387	2.3
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	2	0.391	2.3